These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2472910)

  • 1. Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.
    Fellström B; Lindsjö M; Danielson BG; Karlsson FA; Ljunghall S
    Clin Chim Acta; 1989 Apr; 180(3):213-220. PubMed ID: 2472910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of glycosaminoglycans to sodium urate and uric acid crystals.
    Fellström B; Lindsjö M; Danielson BG; Ljunghall S; Wikström B
    Clin Sci (Lond); 1986 Jul; 71(1):61-4. PubMed ID: 2423287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth.
    Fellström B; Danielson BG; Ljunghall S; Wikström B
    Clin Chim Acta; 1986 Aug; 158(3):229-35. PubMed ID: 2429785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation.
    Ryall RL; Harnett RM; Marshall VR
    J Urol; 1986 Jan; 135(1):174-7. PubMed ID: 3079836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of glycosaminoglycans on calcium oxalate crystal formation].
    Shirane Y; Hamao T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1065-70. PubMed ID: 2214470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of factors affecting calcium oxalate crystalline aggregation.
    Grases F; Costa-Bauzá A
    Br J Urol; 1990 Sep; 66(3):240-4. PubMed ID: 1698500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].
    Fukatani T
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):246-53. PubMed ID: 1710303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glycosaminoglycans on the crystallisation of calcium oxalate.
    Kohri K; Garside J; Blacklock NJ
    Br J Urol; 1989 Jun; 63(6):584-90. PubMed ID: 2502299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Clin Sci (Lond); 1985 Mar; 68(3):369-71. PubMed ID: 2578913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Br J Urol; 1984 Dec; 56(6):594-8. PubMed ID: 6085478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of magnesium on calcium oxalate crystal shapes generated with glycosaminoglycan].
    Shirane Y; Kajimoto M; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):210-5. PubMed ID: 2041268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycosaminoglycans on calcium oxalate crystal aggregation.
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Tokushima J Exp Med; 1989 Dec; 36(3-4):81-5. PubMed ID: 2517714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells and some effects of glycosaminoglycans or cell injuries.
    Ebisuno S; Kohjimoto Y; Tamura M; Ohkawa T
    Eur Urol; 1995; 28(1):68-73. PubMed ID: 8521899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation.
    Bowyer RC; Brockis JG; McCulloch RK
    Clin Chim Acta; 1979 Jul; 95(1):23-28. PubMed ID: 41655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.